X4 Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 65.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.92%	Bain Capital Life Sciences Investors, LLC	16,915,784	US$6.8m	0%	0.67%
8.79%	New Enterprise Associates, Inc.	14,986,793	US$6.0m	0%	0.28%
6.57%	BlackRock, Inc.	11,210,671	US$4.5m	5.01%	no data
4.95%	The Vanguard Group, Inc.	8,440,730	US$3.4m	1.82%	no data
4.91%	Acorn Bioventures	8,374,789	US$3.4m	0%	3.24%
4.18%	OrbiMed Advisors LLC	7,133,515	US$2.9m	0%	0.04%
3.73%	Anders Hove	6,367,131	US$2.6m	0%	no data
2.72%	Kingdon Capital Management, L.L.C.	4,638,683	US$1.9m	0.32%	0.28%
2.51%	Adage Capital Management, L.P.	4,276,315	US$1.7m	0%	no data
2.08%	Perceptive Advisors LLC	3,545,454	US$1.4m	0%	0.03%
2.02%	Geode Capital Management, LLC	3,447,512	US$1.4m	-1.94%	no data
1.8%	AXA Investment Managers S.A.	3,076,941	US$1.2m	0.03%	no data
1.73%	State Street Global Advisors, Inc.	2,952,895	US$1.2m	6.84%	no data
1.49%	Ensign Peak Advisors, Inc.	2,546,458	US$1.0m	0%	no data
1.45%	Medical Strategy GmbH, Asset Management Arm	2,477,357	US$999.6k	0%	0.06%
1.13%	Schonfeld Strategic Advisors LLC	1,920,800	US$775.0k	51.3%	0.01%
0.94%	Pale Fire Capital SE	1,602,792	US$646.7k	805%	0.11%
0.91%	UBS O'Connor LLC	1,549,358	US$625.2k	33.5%	0.05%
0.77%	Northern Trust Global Investments	1,319,599	US$532.5k	25%	no data
0.76%	Sio Capital Management, LLC	1,303,508	US$526.0k	-47.9%	0.25%
0.6%	Paula Ragan	1,025,816	US$413.9k	34.1%	no data
0.48%	Parkman Healthcare Partners LLC	818,727	US$330.4k	1.5%	0.04%
0.42%	AQR Capital Management, LLC	714,565	US$288.3k	68.9%	no data
0.37%	Point72 Asset Management, L.P.	625,052	US$252.2k	15.1%	no data
0.3%	GSA Capital Partners LLP	507,694	US$204.9k	0%	0.02%